Sprucegrove Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-53,658
Closed -$2.79M 51
2018
Q1
$2.79M Sell
53,658
-55,544
-51% -$3M 0.17% 52
2017
Q4
$5.86M Sell
109,202
-14,462
-12% -$802K 0.34% 46
2017
Q3
$7.56M Sell
123,664
-3,039
-2% -$184K 0.42% 44
2017
Q2
$7.75M Sell
126,703
-37,519
-23% -$2.28M 0.46% 45
2017
Q1
$9.96M Sell
164,222
-39,090
-19% -$2.37M 0.51% 42
2016
Q4
$11.4M Sell
203,312
-69,797
-26% -$4.08M 0.56% 41
2016
Q3
$16.3M Sell
273,109
-119,367
-30% -$6.98M 0.68% 40
2016
Q2
$21.6M Sell
392,476
-47,370
-11% -$2.52M 0.89% 33
2016
Q1
$22.2M Sell
439,846
-541,621
-55% -$26.5M 0.89% 34
2015
Q4
$49.5M Sell
981,467
-246,990
-20% -$12.5M 1.41% 27
2015
Q3
$57.9M Sell
1,228,457
-105,691
-8% -$5.61M 1.44% 27
2015
Q2
$72.5M Sell
1,334,148
-109,689
-8% -$6.15M 1.55% 28
2015
Q1
$79.2M Sell
1,443,837
-280,788
-16% -$15.9M 1.59% 24
2014
Q4
$93.5M Sell
1,724,625
-128,842
-7% -$7.18M 1.73% 26
2014
Q3
$105M Sell
1,853,467
-127,856
-6% -$7.18M 1.87% 24
2014
Q2
$109M Sell
1,981,323
-22,060
-1% -$1.2M 1.86% 27
2014
Q1
$109M Sell
2,003,383
-1,126,443
-36% -$58.3M 1.9% 28
2013
Q4
$149M Sell
3,129,826
-321,107
-9% -$14.7M 2.57% 19
2013
Q3
$157M Sell
3,450,933
-789,563
-19% -$36M 2.85% 14
2013
Q2
$188M Buy
+4,240,496
New +$189M 3.41% 10

Other funds holding MRK

Sprucegrove Investment Management's MRK Position: Q2 2018 in Review

Sprucegrove Investment Management sold out of Merck (MRK) in Q2 2018, closing a stake of 53,658 shares — an estimated $2.79M sold.

Sprucegrove Investment Management first reported a position in MRK in Q2 2013 and held it in 20 quarters. The position peaked at $188M in Q2 2013. 2,017 funds tracked by Wall St. Rank hold MRK as of Q2 2018.

  • Sprucegrove Investment Management reported no remaining Merck position as of Q2 2018 after selling out during the quarter.
  • Sprucegrove Investment Management sold 53,658 Merck shares in Q2 2018, an estimated $2.79M.
  • Sprucegrove Investment Management first reported a position in Merck in Q2 2013 and held it in 20 quarters.
  • Sprucegrove Investment Management's Merck position peaked at $188M in Q2 2013.
  • 2,017 funds tracked by Wall St. Rank held Merck as of Q2 2018.

Based on Sprucegrove Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.